| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/18/2004 | US20040053269 Proteases |
| 03/18/2004 | US20040053267 Using rearrangements in nucleotide sequences to stimulate rapid evolution of polypeptides such as antibodies, transport protein, antibodies and toxins in vitro |
| 03/18/2004 | US20040053262 Supressor gene |
| 03/18/2004 | US20040053261 Identifying allelic sequence whch can be used to diagnose and treat urogenital cancers |
| 03/18/2004 | US20040053259 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 03/18/2004 | US20040053256 Detection signal and capture in dipstick assays |
| 03/18/2004 | US20040053255 Using chromatographic strip comprising immobilized nucleotide sequences to diagnose chlamydial infection |
| 03/18/2004 | US20040053254 Late-pcr |
| 03/18/2004 | US20040053253 Sulfate transferase and dna encoding this enzyme |
| 03/18/2004 | US20040053244 Regulation of human galanin receptor-like g protein coupled receptor |
| 03/18/2004 | US20040053243 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 03/18/2004 | US20040053238 Comprises xylanolytic polypeptides for use in food processing/thickening, detergents, textile treatment and paper making |
| 03/18/2004 | US20040053236 Reverse genetic strategy for identifying functional mutations in genes of known sequences |
| 03/18/2004 | US20040053235 Comprises oxidoreductase for generating ascorbic acid in microorganisms |
| 03/18/2004 | US20040053234 Polynucletides that control delta-6 desaturase genes and methods for identifying compounds for modulating delta-6 desaturase |
| 03/18/2004 | US20040053233 Identifying antagonist and/or agonist of neovascularization for treatment and prevention of cancer, reproductive, skin, visual and wound healing disorders |
| 03/18/2004 | US20040053231 Comprises nucleotide sequences coding cbp/p3000 interacting transativators with ed-rich tails (HCITED) diagnosis, prevention and treatment hypoxia, cardioovascular, inflammatory, cancer and stroke disorders |
| 03/18/2004 | US20040053228 Apoptosis inhibitory polypeptides, gene and polynucleotide encoding it and compositions containing the same |
| 03/18/2004 | US20040053227 Transcription factor network discovery methods |
| 03/18/2004 | US20040053226 Comprises nucleotide sequences coding proteolytic enzyme for use in diagnosis, prevention and treatment of liver disorders |
| 03/18/2004 | US20040053225 Comprises expression vector coding nucleotide sequences which form hairpin motifs which can be utilized as tools in gene expression inhibition and in preparation of transient knockout mutants |
| 03/18/2004 | US20040053224 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 03/18/2004 | US20040053223 Detection of HIV-1 by nucleic acid amplification |
| 03/18/2004 | US20040053219 Method for analysing human immunodeficiency virus (HIV) phenotypic characteristics |
| 03/18/2004 | US20040053218 Functional proteomics using double phage display screening |
| 03/18/2004 | US20040053206 Using tissue preservation solution to decrease reperfusion injury of an organ during surgery and/or following removal of organ |
| 03/18/2004 | US20040052857 Vesicle encapsulating an aqueous system of a polymer and can exist as more than one phase depending on temperature and composition |
| 03/18/2004 | US20040052820 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells |
| 03/18/2004 | US20040052819 Addition of histidine amino acids to the cytoplasmic domains of membrane and viral envelope proteins for the purpose of solubilizing, and/or reconstituting viral envelope proteins in lipid containing vesicles |
| 03/18/2004 | US20040052818 Flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy terminal hydrophobic region is not affected by the deletion |
| 03/18/2004 | US20040052817 A nucleic acid sequences encoding Ostertagia ostertagi proteins and parts of such nucleic acid sequences encode an immunogenic fragment of such proteins |
| 03/18/2004 | US20040052816 Recombinant protective protein from streptococcus pneumoniale |
| 03/18/2004 | US20040052814 Fusion proteins for targeted delivery of antimicrobial peptides |
| 03/18/2004 | US20040052813 Polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits and the diagnostic kits |
| 03/18/2004 | US20040052812 Immunogenic complex containing a multi-component viral particle covalently linked to a javelin molecule, wherein the javelin molecule is a peptide which selectively binds to a heat shock protein |
| 03/18/2004 | US20040052802 Attenuated mutant; prevent inferctions, diarrhea; human and veterinary medicine |
| 03/18/2004 | US20040052796 Anticancer agents; antitumor agents; controlling gene expression; quantitative analysis |
| 03/18/2004 | US20040052794 Isolation antibodies; anticancer agents, antitumor agents |
| 03/18/2004 | US20040052789 Novel proteins genes encoding them and method of using the same |
| 03/18/2004 | US20040052788 Cytokine that induces apoptosis |
| 03/18/2004 | US20040052786 Erbb4 antagonists |
| 03/18/2004 | US20040052779 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
| 03/18/2004 | US20040052775 Antigens; induce immunology response; prevent infections; genetic engineering |
| 03/18/2004 | US20040052774 Reducing oxidative stress of plants by increasing glutathione content |
| 03/18/2004 | US20040052773 Production of multi-chain protein from muscle |
| 03/18/2004 | US20040052767 Method for cell adhesion and wound healing |
| 03/18/2004 | US20040052765 Modulate immunology response; isolation nucleic acids; induce immunology response; genetic engineering |
| 03/18/2004 | US20040052764 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| 03/18/2004 | US20040052763 Target antigens; vaccine |
| 03/18/2004 | DE10242763A1 New polynucleotide encoding mutant human glucose transporter, useful for identifying antidiabetic agents that can be used to treat diabetes types I or II |
| 03/18/2004 | DE10242318A1 Orthopoxvirusantigene und deren Verwendung Orthopoxvirusantigene and their use |
| 03/18/2004 | DE10241152A1 Tubulysin-Biosynthese-Gene Tubulysin biosynthesis genes |
| 03/18/2004 | CA2801911A1 Antibody against secreted n-terminal peptide of gpc3 present in blood |
| 03/18/2004 | CA2501065A1 Methods using dsdna to mediate rna interference (rnai) |
| 03/18/2004 | CA2498353A1 Antifreeze proteins isolated from forage grasses and methods for their use |
| 03/18/2004 | CA2498319A1 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 03/18/2004 | CA2498297A1 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | CA2498284A1 Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
| 03/18/2004 | CA2497994A1 Genetic analysis and authentication |
| 03/18/2004 | CA2497902A1 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 03/18/2004 | CA2497892A1 Compositions and methods for tissue specific or inducible inhibition of gene expression |
| 03/18/2004 | CA2497880A1 Methods for assaying protein-protein interactions |
| 03/18/2004 | CA2497873A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | CA2497833A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | CA2497750A1 Orthopoxvirus vectors, genes and products thereof |
| 03/18/2004 | CA2497719A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | CA2497499A1 Use of malate dehydrogenase for nadh regeneration |
| 03/18/2004 | CA2497475A1 Methods of producing a viral vector comprising a membrane protein that binds to sialic acid as a component of the envelope using neuraminidase derived from gram-positive bacteria |
| 03/18/2004 | CA2497420A1 Improved compositions and methods for cdna synthesis |
| 03/18/2004 | CA2497406A1 Short interfering nucleic acid hybrids and methods thereof |
| 03/18/2004 | CA2497350A1 Decoy-oligonucleotide-inhbition of cd40-expression |
| 03/18/2004 | CA2497335A1 Formulation for funnelling nucleic acids into eukaryotic cells |
| 03/18/2004 | CA2497254A1 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 03/18/2004 | CA2496891A1 Novel actin-related cytoskeletal protein lacs |
| 03/18/2004 | CA2496888A1 Epitope sequences |
| 03/18/2004 | CA2496760A1 Method for improving corn starch extractability |
| 03/18/2004 | CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | CA2496517A1 Genome partitioning |
| 03/18/2004 | CA2496233A1 Methods and compositions for the generation of humanized mice |
| 03/18/2004 | CA2495825A1 Variants of the major allergen phl p 1 from timothy grass |
| 03/18/2004 | CA2495779A1 Method for hydrolysing carotenoids esters |
| 03/18/2004 | CA2495555A1 Method for identifying substances having a herbicide action |
| 03/18/2004 | CA2495449A1 Methods of diagnosing cervical cancer |
| 03/18/2004 | CA2492423A1 Exponential amplification of nucleic acids using nicking agents |
| 03/18/2004 | CA2407301A1 Hsp60 sequence from piscirickettsia salmonis |
| 03/17/2004 | EP1398389A2 Variant of HNF-1alpha gene having a single nucleotide polymorphism and variant of protein encoded by the same |
| 03/17/2004 | EP1398383A1 Protein production method |
| 03/17/2004 | EP1398382A1 Sd1 gene involved in plant semidwarfing and uses thereof |
| 03/17/2004 | EP1398381A1 A microbial oxidoreductase |
| 03/17/2004 | EP1398380A1 Orthopoxvirus antigens and use thereof |
| 03/17/2004 | EP1398379A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 03/17/2004 | EP1398378A1 Nucleic acids isolated in neuroblastoma |
| 03/17/2004 | EP1398377A1 Growth differentation Factor-7 |
| 03/17/2004 | EP1398375A1 Recombination process for recombining fragments of variant polynucleotides |
| 03/17/2004 | EP1398371A1 Infectious HCV pseudo-particles containing functional E1, E2 envelope proteins |
| 03/17/2004 | EP1398367A1 Cleaning compositions containing multiply-substituted protease variants |
| 03/17/2004 | EP1398328A1 Hydroxyalkyl starch derivatives |
| 03/17/2004 | EP1398327A1 Method of producing hydroxyalkyl starch derivatives |
| 03/17/2004 | EP1398326A2 Monoclonal antibodies against recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 03/17/2004 | EP1398325A1 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |